AUSTIN, Texas–(BUSINESS WIRE)–Vellum Health, the mobile healthcare platform delivering advanced intravenous (IV) services at the bedside, today announced the close of its Series A funding round. The round was led by FCA Venture Partners, with participation from Green Park & Golf Ventures, and follow-on investment from seed round angel investors.

“Vellum is solving real operational and clinical challenges with a patient-centered, mobile-first model.”Share

The company is also announcing the launch of its new brand—Vellum Health—which unifies a portfolio of acquired vascular access companies into a single, tech-enabled care delivery platform.

Vellum Health provides mobile IV access, infusion therapy, and on-site transfusion services to patients in skilled nursing facilities, long-term acute care centers, and homes. By enabling hospitals, payors, and post-acute providers to extend high-quality care into lower-cost, more convenient settings, Vellum reduces unnecessary hospitalizations and improves patient outcomes.

“This funding marks a pivotal milestone for our company,” said Tyler Payne, CEO of Vellum Health. “It allows us to scale nationally while launching a brand that represents our commitment to smarter, value-driven care. Our model delivers expert care directly to the bedside—anytime, anywhere.”

With this round of funding, Vellum Health will accelerate its expansion into new markets and further invest in its proprietary AI-powered technology platform. This platform enables secure EMR integration, intelligent care navigation, dynamic documentation, and proactive patient identification—serving as the connective tissue between providers, payors, and clinical teams.

“Vellum is solving real operational and clinical challenges with a patient-centered, mobile-first model,” said Matt King, Managing Partner at FCA Venture Partners. “We’re excited to support their growth and believe their model is uniquely positioned to meet the needs of an evolving healthcare landscape.”

“Our team of early investors saw something powerful in Vellum’s vision from the very beginning,” said Michael Sanderson, a seed round investor. “We’re proud to continue supporting this next phase of growth as Vellum transforms how and where care is delivered. Their ability to combine technology, clinical quality, and operational excellence is exactly what modern healthcare needs.”

Vellum Health currently serves facilities and home-based patients across multiple states and partners with payors, hospitals, and post-acute care providers to extend access to complex care without requiring hospitalization.

About Vellum Health

Vellum Health is the first and only platform for on-demand IV enablement and therapy that integrates advanced technology, highly trained clinicians, and mobile service delivery. Vellum’s offerings include mobile IV access (PIVs, Midlines, PICCs), on-demand IV infusions for hydration, infection, cognition, and nutrition, on-site blood transfusions, and AI-powered care coordination. By aligning with health systems, payors, and senior care organizations, Vellum helps deliver safer, faster, and more cost-effective treatment wherever patients are.

To learn more, visit vellum.health or contact info@vellum.health

About FCA Venture Partners:

FCA Venture Partners is a venture capital firm investing in companies transforming healthcare through innovative technology and services that improve patient outcomes, empower providers, lower costs, and redefine how care is delivered. FCA manages over $285 million and invests across the Series Seed to Series B stages. FCA brings portfolio companies valuable healthcare insights, connections, and board-level experience to accelerate growth and build disruptive and sustainable businesses. Based in Nashville and Charlotte, the FCA team has a decades-long track record including more than 60 investments in the rapidly changing healthcare industry.

Contacts

Media Contact:
press@vellum.health

(c)2025 Business Wire, Inc., All rights reserved.